{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:50:19Z","timestamp":1761709819320,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON 2015-12 eDETECT"],"award-info":[{"award-number":["CVON 2015-12 eDETECT"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCL Hospitals NIHR Biomedical Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In relatives of index patients with dilated cardiomyopathy and arrhythmogenic cardiomyopathy, early detection of disease onset is essential to prevent sudden cardiac death and facilitate early treatment of heart failure. However, the optimal screening interval and combination of diagnostic techniques are unknown. The clinical course of disease in index patients and their relatives is variable due to incomplete and age-dependent penetrance. Several biomarkers, electrocardiographic and imaging (echocardiographic deformation imaging and cardiac magnetic resonance imaging) techniques are promising non-invasive methods for detection of subclinical cardiomyopathy. However, these techniques need optimisation and integration into clinical practice. Furthermore, determining the optimal interval and intensity of cascade screening may require a\u00a0personalised approach. To address this, the CVON-eDETECT (early detection of disease in cardiomyopathy mutation carriers) consortium aims to integrate electronic health record data from long-term follow-up, diagnostic data sets, tissue and plasma samples in a\u00a0multidisciplinary biobank environment to provide personalised risk stratification for heart failure and sudden cardiac death. Adequate risk stratification may lead to personalised screening, treatment and optimal timing of implantable cardioverter defibrillator implantation. In this article, we describe non-invasive diagnostic techniques used for detection of subclinical disease in relatives of index patients with dilated cardiomyopathy and arrhythmogenic cardiomyopathy.<\/jats:p>","DOI":"10.1007\/s12471-021-01542-1","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T19:07:31Z","timestamp":1612292851000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk stratification and subclinical phenotyping of dilated and\/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium"],"prefix":"10.1007","volume":"29","author":[{"given":"R. W.","family":"Roudijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bourfiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"van Lint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"van der Voorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S. J. M.","family":"te Riele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. P.","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Christiaans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A. B.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Remme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"van Tintelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"1542_CR1","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1161\/CIRCULATIONAHA.105.609719","volume":"113","author":"JP van Tintelen","year":"2006","unstructured":"van Tintelen\u00a0JP, Entius\u00a0MM, Bhuiyan\u00a0ZA, et al. Plakophilin\u20112 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circulation. 2006;113:1650\u20138.","journal-title":"Circulation"},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA van der Zwaag","year":"2012","unstructured":"van der Zwaag\u00a0PA, van Rijsingen\u00a0IA, Asimaki\u00a0A, et\u00a0al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 2012;14:1199\u2013207.","journal-title":"Eur J Heart Fail"},{"key":"1542_CR3","doi-asserted-by":"crossref","first-page":"e002355","DOI":"10.1161\/CIRCGEN.118.002355","volume":"11","author":"J Ingles","year":"2018","unstructured":"Ingles\u00a0J, Bagnall\u00a0RD, Yeates\u00a0L, et\u00a0al. Concealed arrhythmogenic right ventricular cardiomyopathy in sudden unexplained cardiac death events. Circ Genom Precis Med. 2018;11:e2355.","journal-title":"Circ Genom Precis Med"},{"key":"1542_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12471-019-1270-1","volume":"27","author":"LP Bosman","year":"2019","unstructured":"Bosman\u00a0LP, Verstraelen\u00a0TE, van Lint\u00a0FHM, et\u00a0al. The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update. Neth Heart\u00a0J. 2019;27:480\u20136.","journal-title":"Neth Heart J"},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","volume":"8","author":"JA Groeneweg","year":"2015","unstructured":"Groeneweg\u00a0JA, Bhonsale\u00a0A, James\u00a0CA, et al. Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members. Circ Cardiovasc Genet. 2015;8:437\u201346.","journal-title":"Circ Cardiovasc Genet"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","volume":"36","author":"A Bhonsale","year":"2015","unstructured":"Bhonsale\u00a0A, Groeneweg\u00a0JA, James\u00a0CA, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart\u00a0J. 2015;36:847\u201355.","journal-title":"Eur Heart J"},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","volume":"7","author":"IA van Rijsingen","year":"2014","unstructured":"van Rijsingen\u00a0IA, van der Zwaag\u00a0PA, Groeneweg\u00a0JA, et\u00a0al. Outcome in phospholamban R14del carriers: results of a\u00a0large multicentre cohort study. Circ Cardiovasc Genet. 2014;7:455\u201365.","journal-title":"Circ Cardiovasc Genet"},{"key":"1542_CR8","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin\u00a0JA, McKenna\u00a0WJ, Abrams\u00a0DJ, et\u00a0al. HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16:e301\u2013e72.","journal-title":"Heart Rhythm"},{"key":"1542_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jacc.2014.04.044","volume":"64","author":"AS te Riele","year":"2014","unstructured":"te Riele\u00a0AS, James\u00a0CA, Rastegar\u00a0N, et al. Yield of serial evaluation in at-risk family members of patients with ARVD\/C. J\u00a0Am Coll Cardiol. 2014;64:293\u2013301.","journal-title":"J Am Coll Cardiol"},{"key":"1542_CR10","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.jacc.2016.08.061","volume":"68","author":"TP Mast","year":"2016","unstructured":"Mast\u00a0TP, Teske\u00a0AJ, Walmsley\u00a0J, et\u00a0al. Right ventricular imaging and computer simulation for electromechanical substrate characterization in arrhythmogenic right ventricular cardiomyopathy. J\u00a0Am Coll Cardiol. 2016;68:2185\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"1542_CR11","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto\u00a0YM, Elliott\u00a0PM, Arbustini\u00a0E, et al. Proposal for a\u00a0revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a\u00a0position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart\u00a0J. 2016;37:1850\u20138.","journal-title":"Eur Heart J"},{"key":"1542_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","volume":"121","author":"FI Marcus","year":"2010","unstructured":"Marcus\u00a0FI, McKenna\u00a0WJ, Sherrill\u00a0D, et\u00a0al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533\u201341.","journal-title":"Circulation"},{"key":"1542_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ejhf.1815","volume":"22","author":"G Finocchiaro","year":"2020","unstructured":"Finocchiaro\u00a0G, Merlo\u00a0M, Sheikh\u00a0N, et\u00a0al. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail. 2020;22:1097\u2013107.","journal-title":"Eur J Heart Fail"},{"key":"1542_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.hrthm.2018.01.031","volume":"15","author":"LP Bosman","year":"2018","unstructured":"Bosman\u00a0LP, Sammani\u00a0A, James\u00a0CA, et al. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a\u00a0systematic review and meta-analysis. Heart Rhythm. 2018;15:1097\u2013107.","journal-title":"Heart Rhythm"},{"key":"1542_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","volume":"394","author":"ZI Attia","year":"2019","unstructured":"Attia\u00a0ZI, Noseworthy\u00a0PA, Lopez-Jimenez\u00a0F, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a\u00a0retrospective analysis of outcome prediction. Lancet. 2019;394:861\u20137.","journal-title":"Lancet"},{"key":"1542_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCRESAHA.112.279315","volume":"112","author":"Y Rudy","year":"2013","unstructured":"Rudy\u00a0Y. Noninvasive electrocardiographic imaging of arrhythmogenic substrates in humans. Circ Res. 2013;112:863\u201374.","journal-title":"Circ Res"},{"key":"1542_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3389\/fphys.2018.01305","volume":"9","author":"M Cluitmans","year":"2018","unstructured":"Cluitmans\u00a0M, Brooks\u00a0DH, MacLeod\u00a0R, et\u00a0al. Validation and opportunities of electrocardiographic imaging: from technical achievements to clinical applications. Front Physiol. 2018;9:1305.","journal-title":"Front Physiol"},{"key":"1542_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12968-017-0380-4","volume":"19","author":"M Bourfiss","year":"2017","unstructured":"Bourfiss\u00a0M, Vigneault\u00a0DM, Aliyari Ghasebeh\u00a0M, et\u00a0al. Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia\/ cardiomyopathy: a\u00a0multisoftware feasibility and clinical implementation study. J\u00a0Cardiovasc Magn Reson. 2017;19:66.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2 Pt 2","key":"1542_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jcmg.2019.08.014","volume":"3","author":"K Taha","year":"2020","unstructured":"Taha\u00a0K, Mast\u00a0TP, Cramer\u00a0MJ, et\u00a0al. Evaluation of disease progression in arrhythmogenic cardiomyopathy: the change of echocardiographic deformation characteristics over time. JACC Cardiovasc Imaging. 2020;3(2 Pt 2):631\u20134.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1542_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jcmg.2018.01.012","volume":"12","author":"TP Mast","year":"2019","unstructured":"Mast\u00a0TP, Taha\u00a0K, Cramer\u00a0MJ, et\u00a0al. The prognostic value of right ventricular deformation imaging in early arrhythmogenic right ventricular cardiomyopathy. JACC Cardiovasc Imaging. 2019;12:446\u201355.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8 Pt 1","key":"1542_CR21","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.jcmg.2019.01.023","volume":"12","author":"M Bourfiss","year":"2019","unstructured":"Bourfiss\u00a0M, Prakken\u00a0NHJ, van der Heijden\u00a0JF, et\u00a0al. Diagnostic value of native T1 mapping in arrhythmogenic right ventricular cardiomyopathy. JACC Cardiovasc Imaging. 2019;12(8 Pt 1):1580\u20132.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1542_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally\u00a0EM, Mestroni\u00a0L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121:731\u201348.","journal-title":"Circ Res"},{"key":"1542_CR23","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1093\/eurheartj\/ehz435","volume":"40","author":"R Tadros","year":"2019","unstructured":"Tadros\u00a0R, Tan\u00a0HL, El Mathari\u00a0S, et al. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores. Eur Heart\u00a0J. 2019;40:3097\u2013107.","journal-title":"Eur Heart J"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","volume":"39","author":"D Chatterjee","year":"2018","unstructured":"Chatterjee\u00a0D, Fatah\u00a0M, Akdis\u00a0D, et\u00a0al. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. Eur Heart\u00a0J. 2018;39:3932\u201344.","journal-title":"Eur Heart J"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1586\/14779072.2015.1053873","volume":"13","author":"CJ Coats","year":"2015","unstructured":"Coats\u00a0CJ, Heywood\u00a0WE, Mills\u00a0K, Elliott\u00a0PM. Current applications of biomarkers in cardiomyopathies. Expert Rev Cardiovasc Ther. 2015;13:825\u201337.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1542_CR26","doi-asserted-by":"publisher","first-page":"e003688","DOI":"10.1161\/CIRCEP.115.003688","volume":"9","author":"A Asimaki","year":"2016","unstructured":"Asimaki\u00a0A, Protonotarios\u00a0A, James\u00a0CA, et\u00a0al. Characterizing the molecular pathology of arrhythmogenic cardiomyopathy in patient buccal mucosa cells. Circ Arrhythm Electrophysiol. 2016;9:e3688.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1542_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.hfc.2017.08.010","volume":"14","author":"MZ Israr","year":"2018","unstructured":"Israr\u00a0MZ, Heaney\u00a0LM, Suzuki\u00a0T. Proteomic biomarkers of heart failure. Heart Fail Clin. 2018;14:93\u2013107.","journal-title":"Heart Fail Clin"},{"issue":"7","key":"1542_CR28","doi-asserted-by":"publisher","first-page":"e025660","DOI":"10.1136\/bmjopen-2018-025660","volume":"9","author":"LM van den Heuvel","year":"2019","unstructured":"van den Heuvel\u00a0LM, Hoedemaekers\u00a0YM, Baas\u00a0AF, van Tintelen\u00a0JP, Smets\u00a0EMA, Christiaans\u00a0I. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a\u00a0randomised controlled trial. BMJ Open. 2019;9(7):e25660.","journal-title":"BMJ Open"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12471-019-1288-4","volume":"27","author":"A Sammani","year":"2019","unstructured":"Sammani\u00a0A, Jansen\u00a0M, Linschoten\u00a0M, et\u00a0al. UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking. Neth Heart\u00a0J. 2019;27:426\u201334.","journal-title":"Neth Heart J"},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","volume":"40","author":"J Cadrin-Tourigny","year":"2019","unstructured":"Cadrin-Tourigny\u00a0J, Bosman\u00a0LP, Nozza\u00a0A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart\u00a0J. 2019;40:1850\u20138.","journal-title":"Eur Heart J"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-021-01542-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-021-01542-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-021-01542-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:47:00Z","timestamp":1671018420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-021-01542-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s12471-021-01542-1","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"type":"print","value":"1568-5888"},{"type":"electronic","value":"1876-6250"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"14 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.W.\u00a0Roudijk, K.\u00a0Taha, M.\u00a0Bourfiss, P.\u00a0Loh, L.\u00a0van den Heuvel, M.J.\u00a0Boonstra, F.\u00a0van Lint, S.M.\u00a0van der Voorn, A.S.J.M.\u00a0te Riele, L.P.\u00a0Bosman, I.\u00a0Christiaans, T.A.B.\u00a0van Veen, C.A.\u00a0Remme, M.P.\u00a0van den Berg, J.P.\u00a0van Tintelen and F.W.\u00a0Asselbergs declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}